Incidence of Cigarette Smoking Relapse Among Individuals Who Switched to e-Cigarettes or Other Tobacco Products.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
entrez:
19
10
2021
pubmed:
20
10
2021
medline:
12
1
2022
Statut:
epublish
Résumé
Although e-cigarettes are not approved as a cessation device, many who smoke believe that e-cigarettes will help them quit cigarette smoking successfully. To assess whether people who recently quit smoking and who had switched to e-cigarettes or another tobacco product were less likely to relapse to cigarette smoking compared with those who remained tobacco free. This cohort study analyzed a nationally representative sample of US households that participated in 4 waves of the Population Assessment of Tobacco and Health Study (conducted 2013 through 2017), combining 2 independent cohorts each with 3 annual surveys. Eligible participants were individuals who smoked at baseline, had recently quit at the first follow-up, and completed the second follow-up survey. Use of e-cigarettes or alternate tobacco products at follow-up 1 after recently quitting smoking. Weighted percentage of participants with over 12 months abstinence by follow-up 2. Of a total of 13 604 participants who smoked cigarettes at baseline, 9.4% (95% CI, 8.7%-10.0%) recently had quit smoking (mean age, 41.9; 95% CI, 39.7-46.6 years; 641 [43.2%] women) Of these, 22.8% (95% CI, 19.7%-26.0%) had switched to e-cigarettes, with 17.6% (95% CI, 14.8%-20.5%) using them daily. A total of 37.1% (95% CI, 33.7%-40.4%) used a noncigarette tobacco product and 62.9% (95% CI, 59.6%-66.3%) were tobacco free. Rates of switching to e-cigarettes were highest for those who were in the top tertile of tobacco dependence (31.3%; 95% CI, 25.0%-37.7%), were non-Hispanic White (26.4%; 95% CI, 22.3%-30.4%), and had higher incomes (annual income ≥$35 000, 27.5%; 95% CI, 22.5%-32.4% vs <$35 000, 19.3%; 95% CI, 16.3%-22.3%). At follow-up 2, unadjusted relapse rates were similar among those who switched to different tobacco products (for any tobacco product: successfully quit, 41.5%; 95% CI, 36.2%-46.9%; relapsed with significant requit, 17.0%; 95% CI, 12.4%-21.6%; currently smoking, 36.2%; 95% CI, 30.9%-41.4%). Controlled for potential confounders, switching to any tobacco product was associated with higher relapse rate than being tobacco free (adjusted risk difference, 8.5%; 95% CI, 0.3%-16.6%). Estimates for those who switched to e-cigarettes, whether daily or not, were not significant. While individuals who switched from cigarettes to e-cigarettes were more likely to relapse, they appeared more likely to requit and be abstinent for 3 months at follow-up 2 (17.0%; 95% CI, 12.4%-21.6% vs 10.4%; 95% CI, 8.0%-12.9%). This large US nationally representative study does not support the hypothesis that switching to e-cigarettes will prevent relapse to cigarette smoking.
Identifiants
pubmed: 34665239
pii: 2785237
doi: 10.1001/jamanetworkopen.2021.28810
pmc: PMC8527352
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2128810Commentaires et corrections
Type : CommentIn
Références
PLoS One. 2020 Sep 2;15(9):e0237938
pubmed: 32877429
Nicotine Tob Res. 2019 Feb 18;21(3):267
pubmed: 29931122
Prev Chronic Dis. 2017 Apr 13;14:E32
pubmed: 28409740
Am J Public Health. 2021 Feb;111(2):230-246
pubmed: 33351653
JAMA. 2020 Nov 10;324(18):1844-1854
pubmed: 33170240
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464
pubmed: 28056007
Drug Alcohol Depend. 2019 Jun 1;199:10-17
pubmed: 30978519
Nicotine Tob Res. 2019 Feb 18;21(3):278-284
pubmed: 30346585
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Int J Environ Res Public Health. 2019 Dec 11;16(24):
pubmed: 31835841
JAMA Netw Open. 2020 Jun 1;3(6):e204813
pubmed: 32501492
Drug Alcohol Depend. 2021 Jul 1;224:108724
pubmed: 33940324
Am J Epidemiol. 2020 Dec 1;189(12):1529-1537
pubmed: 32715314
Drug Alcohol Depend. 2020 Sep 1;214:108134
pubmed: 32629146
Am J Epidemiol. 2018 Nov 1;187(11):2397-2404
pubmed: 29955810
Tob Control. 2007 Apr;16(2):85-90
pubmed: 17400944
J Natl Cancer Inst. 1997 Apr 16;89(8):572-6
pubmed: 9106646
Cochrane Database Syst Rev. 2019 Oct 28;2019(10):
pubmed: 31684681
Environ Int. 2019 Feb;123:201-208
pubmed: 30530162
Tob Control. 2017 Jul;26(4):371-378
pubmed: 27507901